488 related articles for article (PubMed ID: 25639592)
1. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
McDonagh T; Macdougall IC
Eur J Heart Fail; 2015 Mar; 17(3):248-62. PubMed ID: 25639592
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.
Anker SD; Colet JC; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Mori C; von Eisenhart Rothe B; Pocock S; Poole-Wilson PA; Ponikowski P;
Eur J Heart Fail; 2009 Nov; 11(11):1084-91. PubMed ID: 19875408
[TBL] [Abstract][Full Text] [Related]
3. Iron deficiency in heart failure.
Dinatolo E; Dasseni N; Metra M; Lombardi C; von Haehling S
J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):706-716. PubMed ID: 30222663
[TBL] [Abstract][Full Text] [Related]
4. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
Filippatos G; Farmakis D; Colet JC; Dickstein K; Lüscher TF; Willenheimer R; Parissis J; Gaudesius G; Mori C; von Eisenhart Rothe B; Greenlaw N; Ford I; Ponikowski P; Anker SD
Eur J Heart Fail; 2013 Nov; 15(11):1267-76. PubMed ID: 23787722
[TBL] [Abstract][Full Text] [Related]
5. Iron substitution in the treatment of chronic heart failure.
Gstrein C; Meyer M; Anabitarte P
Swiss Med Wkly; 2017; 147():w14453. PubMed ID: 28695549
[TBL] [Abstract][Full Text] [Related]
6. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
Comin-Colet J; Lainscak M; Dickstein K; Filippatos GS; Johnson P; Lüscher TF; Mori C; Willenheimer R; Ponikowski P; Anker SD
Eur Heart J; 2013 Jan; 34(1):30-8. PubMed ID: 22297124
[TBL] [Abstract][Full Text] [Related]
7. Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.
Gutzwiller FS; Pfeil AM; Comin-Colet J; Ponikowski P; Filippatos G; Mori C; Braunhofer PG; Szucs TD; Schwenkglenks M; Anker SD
Int J Cardiol; 2013 Oct; 168(4):3878-83. PubMed ID: 23870642
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
[TBL] [Abstract][Full Text] [Related]
9. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
[TBL] [Abstract][Full Text] [Related]
10. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
[TBL] [Abstract][Full Text] [Related]
11. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
Gordon M; Sinopoulou V; Iheozor-Ejiofor Z; Iqbal T; Allen P; Hoque S; Engineer J; Akobeng AK
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013529. PubMed ID: 33471939
[TBL] [Abstract][Full Text] [Related]
12. Ferric carboxymaltose: a review of its use in iron deficiency.
Keating GM
Drugs; 2015 Jan; 75(1):101-27. PubMed ID: 25428711
[TBL] [Abstract][Full Text] [Related]
13. [Iron deficiency : a new target in treating chronic heart failure ?].
Borgeaud M; Perrier A
Rev Med Suisse; 2016 Oct; 12(535):1747-1751. PubMed ID: 28692214
[TBL] [Abstract][Full Text] [Related]
14. Iron Deficiency Treatment in Patients with Heart Failure.
Jankowska EA; Drozd M; Ponikowski P
Handb Exp Pharmacol; 2017; 243():561-576. PubMed ID: 28405775
[TBL] [Abstract][Full Text] [Related]
15. [Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond].
Češka R
Vnitr Lek; 2014 Dec; 60(12):1033-9. PubMed ID: 25692829
[TBL] [Abstract][Full Text] [Related]
16. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
Lyseng-Williamson KA; Keating GM
Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
[TBL] [Abstract][Full Text] [Related]
17. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
Cases Amenós A; Ojeda López R; Portolés Pérez JM;
Nefrologia; 2017; 37(6):587-591. PubMed ID: 28610806
[TBL] [Abstract][Full Text] [Related]
18. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Cunha GJL; Rocha BML; Menezes Falcão L
Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
[TBL] [Abstract][Full Text] [Related]
19. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
20. Iron deficiency and anaemia in bariatric surgical patients: causes, diagnosis and proper management.
Muñoz M; Botella-Romero F; Gómez-Ramírez S; Campos A; García-Erce JA
Nutr Hosp; 2009; 24(6):640-54. PubMed ID: 20049366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
